About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Epithelioid Sarcoma Natural History Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03837678

Epithelioid Sarcoma Natural History Study

This study is a multi-center, non-interventional retrospective medical records review. The study will involve identification of medical records of patients with confirmed locally advanced unresectable...

Lead sponsor: Epizyme, Inc.•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Epizyme, Inc.

Collaborators

Analysis Group, Inc.

The sampling period will span from January 1, 2000 to December 31, 2017. As the chart abstraction dates may be different across institutions due to contracting and other logistical issues, to avoid seeing biased outcomes that may be related to this type of heterogeneity, a consistent study end date will be imposed for all patients when conducting the analysis. Information before this study end date will be analyzed and used to conduct the analysis.

Age

10 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosed with histologically confirmed, locally advanced unresectable or metastatic Epithelioid Sarcoma (ES) requiring systemic therapy during between January 1, 2000 and December 31, 2017. The date of the confirmed locally advanced unresectable or metastatic ES diagnosis is designated as the index date.
•Patients may have a date of ES diagnosis at an earlier stage prior to 2000 and still be eligible for the study
•Initiation of treatment with any systemic anti-cancer therapy for the treatment of their locally advanced unresectable or metastatic ES between January 1, 2000 and December 31, 2017
•At least 10 years of age at the index date

Related studies

RECRUITINGPhase 1/2

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

NCT06625190 · Neuroblastoma, Rhabdomyosarcoma, and more

An Observational Study on Epithelioid Sarcoma

NCT03099681 · Epithelioid Sarcoma

RECRUITINGPhase 2

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

NCT06277154 · Leiomyosarcoma, Liposarcoma, and more

Active Not RecruitingPhase 1/2

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

NCT05407441 · Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, and more

Active Not RecruitingPhase 2

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

NCT04416568 · Malignant Rhabdoid Tumor, Rhabdoid Tumor of the Kidney, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 7, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment74

Start dateJun 2018

Last updatedMar 7, 2024

Condition

Epithelioid Sarcoma

Locations shown

University of Colorado Cancer Center

Denver, Colorado

Dana Farber Cancer Institute

Boston, Massachusetts

University of Michigan Comprehensive Cancer Center

Ann Arbor, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions